Sarah Fernandes

October 20, 2023

Sarah Fernandes has more than 15 years of experience in scientific research and project management in the biotech industry and academia. At Pheast, Sarah is the director of project management, overseeing multiple initiatives in several departments. Prior to joining Pheast, she held project management positions at MyoKardia, Bristol Myers Squibb and Circle Pharma. In these roles, Sarah supported IND filing and initial drug development of therapies in several therapeutic areas, including cardiovascular, neurology, and oncology. Prior to her roles in project management, she was a research scientist at Gilead Sciences and MyoKardia (acquired by Bristol Myers Squibb). Sarah completed a postdoctoral fellowship in Cardiac Cell Therapy at the University of Washington and received a Ph.D. in Pharmacology from Pays de Loire University and a Pharm.D. from Burgundy University, both in France.